| Target and Pathway |
Top |
| Target(s) |
B-lymphocyte surface antigen B4 (CD19) |
Target Info
|
CAR-T-Cell-Therapy(Dual specific) |
[1] |
| T-cell-specific surface glycoprotein CD28 (CD28) |
Target Info
|
CAR-T-Cell-Therapy(Dual specific) |
[1] |
|
KEGG Pathway
|
Cell adhesion molecules (CAMs)
|
|
T cell receptor signaling pathway
|
|
Intestinal immune network for IgA production
|
|
Type I diabetes mellitus
|
|
Measles
|
|
Autoimmune thyroid disease
|
|
Systemic lupus erythematosus
|
|
Rheumatoid arthritis
|
|
Allograft rejection
|
|
Graft-versus-host disease
|
|
Viral myocarditis
|
|
PI3K-Akt signaling pathway
|
|
Hematopoietic cell lineage
|
|
B cell receptor signaling pathway
|
|
Epstein-Barr virus infection
|
|
Primary immunodeficiency
|
|
NetPath Pathway
|
TCR Signaling Pathway
|
|
IL-7 Signaling Pathway
|
|
Panther Pathway
|
T cell activation
|
|
B cell activation
|
|
Pathway Interaction Database
|
TCR signaling in naï
|
|
|
|
TCR signaling in naï
|
|
|
|
IL12 signaling mediated by STAT4
|
|
BCR signaling pathway
|
|
Reactome
|
PIP3 activates AKT signaling
|
|
Constitutive Signaling by Aberrant PI3K in Cancer
|
|
CD28 co-stimulation
|
|
CD28 dependent PI3K/Akt signaling
|
|
CD28 dependent Vav1 pathway
|
|
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
|
|
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
|
WikiPathways
|
TCR Signaling Pathway
|
|
Inflammatory Response Pathway
|
|
Host Interactions of HIV factors
|
|
PIP3 activates AKT signaling
|
|
T-Cell Receptor and Co-stimulatory Signaling
|
|
Allograft Rejection
|
|
Costimulation by the CD28 family
|
|
Human Complement System
|
|
Signaling by the B Cell Receptor (BCR)
|
|
B Cell Receptor Signaling Pathway
|
|
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
|
